EJIM High-impact Articles
Explore the Future of Internal Medicine
Discover a selection of high-impact articles from the European Journal of Internal Medicine, featuring innovative research. These studies address critical health challenges and offer fresh insights that can transform patient care. Join us in exploring these groundbreaking findings and contribute to the ongoing conversation in internal medicine. Together, let’s shape a healthier future.
How epigenetics impacts on human diseases by A. Farsetti et al.
Mortality and causes of death in systemic lupus erythematosus over the last decade: Data from a large population-based study by M. Zen el al.
Metabolically healthy obesity: Misleading phrase or healthy phenotype? By C. Tanriover et al.
Timeline analysis of clinical severity of COVID-19 in the general population by C. Mattiuzzi and G. Lippi
Predictive value of Killip classification in MINOCA patients by M. Armillotta et al.
Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism by M.C. Vedovati et al.
Hyperglycemia drives the transition from pre-frailty to frailty: The Monteforte study by P. Mone et al.
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices by G. Boriani et al.
Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population by N. Suthahar et al.
Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants by K. Kaneda et al.
The effect of sodium-glucose cotransporter-2 inhibitors on cardiac structure remodeling and function: A meta-analysis of randomized controlled trials by G. Fan and D-L. Guo
De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy? by P. Sabouret et al.
Relationships between education and non-alcoholic fatty liver disease by F. Koutny et al.
A new strategy for anticoagulation: The factor XI inhibitors by M.C. Vedovati et al.
Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease by A. Mellemkjær et al.
Natural history of metabolic dysfunction-associated steatotic liver disease by V. Lekakis and G.V. Papatheodoridis
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations? by P. Portincasa et al.
Non-invasive testing and risk-stratification in patients with MASLD by Mirko Zoncapè et al.
Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis by I. Kyriakoulis et al.
Early prediction of ventilator-associated pneumonia with machine learning models: A systematic review and meta-analysis of prediction model performance by T. Frondelius et al.
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? by G. Boriani et al.
The Long-COVID autonomic syndrome in hospitalized patients: A one-year prospective cohort study by S. Rigo et al.
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients by G. Boriani et al.
The role of adherence in patients with chronic diseases by M. Burnier
Role of sex and gender-related variables in development of metabolic syndrome: A prospective cohort study by P. Alipour et al.
Kidney function and other associated factors of sarcopenia in community-dwelling older adults: The SCOPE study by R. Moreno-Gonzalez et al.
Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease by A. Armandi and E. Bugianesi
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study by Paruga et al.